Neurontin Capsule
NDC Package 0071-0803-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Neurontin (gabapentin) capsules is gabapentin is used with other medications to prevent and control seizures. This formulation utilizes a capsule delivery system. Marketed by Parke-davis Div Of Pfizer Inc, this product is identified by NDC 0071-0803 and is authorized under FDA application NDA020235.

Identification & Billing

NDC Package Code
0071-0803-40
Package Description
50 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
00071080340
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Neurontin
Non-Proprietary Name
Gabapentin
Substance Name
Gabapentin
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Regulatory & Marketing

Labeler Name
Parke-davis Div Of Pfizer Inc
Product Type
Human Prescription Drug
FDA Application #
NDA020235
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-30-1993
End Marketing Date
07-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0071-0803). Click a package code to view its specific billing and regulatory data.

100 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0071-0803-40 identifies a specific commercial package of 50 blister pack in 1 carton / 1 capsule in 1 blister pack of Neurontin, a human prescription drug labeled by Parke-davis Div Of Pfizer Inc. This capsule is formulated for oral use and contains gabapentin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Parke-davis Div Of Pfizer Inc on December 30, 1993.

What are the primary indications for this medication?

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

How is this Parke-davis Div Of Pfizer Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00071080340. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0071-0803-40
11-Digit CMS (5-4-2)
00071-0803-40

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.